Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara E Murray

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsBarbara E Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
The Antibacterial Resistance Leadership Group: First StepsBarbara E Murray, Amanda Jezek
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic optionsKumthorn Malathum, Barbara E. Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic?Arnold S Bayer, Barbara E Murray
The New England Journal of Medicine|January 31, 2009
Antibiotic-resistant bugs in the 21st century--a clinical super-challengeCesar A Arias, Barbara E Murray
Antimicrobial Agents and Chemotherapy|March 28, 2012
Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection modelKavindra V Singh, Barbara E Murray
Antimicrobial Agents and Chemotherapy|December 24, 2004
Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycinKavindra V Singh, Barbara E Murray
The Journal of Infectious Diseases|March 1, 2013
Could a phosphotransferase system provide the means to control outbreaks of Enterococcus faecium infection?Sudha R Somarajan, Barbara E Murray
Antimicrobial Agents and Chemotherapy|March 13, 2019
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by <i>Enterococcus faecalis</i> Is Associated with Increased Resistance to Ceftriaxone and CarbapenemsKavindra V Singh, Barbara E Murray
Nature Reviews. Microbiology|March 17, 2012
The rise of the Enterococcus: beyond vancomycin resistanceCesar A Arias, Barbara E Murray
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsBarbara E Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
The Antibacterial Resistance Leadership Group: First StepsBarbara E Murray, Amanda Jezek
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic optionsKumthorn Malathum, Barbara E. Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic?Arnold S Bayer, Barbara E Murray
The New England Journal of Medicine|January 31, 2009
Antibiotic-resistant bugs in the 21st century--a clinical super-challengeCesar A Arias, Barbara E Murray
Antimicrobial Agents and Chemotherapy|March 28, 2012
Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection modelKavindra V Singh, Barbara E Murray
Antimicrobial Agents and Chemotherapy|December 24, 2004
Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycinKavindra V Singh, Barbara E Murray
The Journal of Infectious Diseases|March 1, 2013
Could a phosphotransferase system provide the means to control outbreaks of Enterococcus faecium infection?Sudha R Somarajan, Barbara E Murray
Antimicrobial Agents and Chemotherapy|March 13, 2019
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by <i>Enterococcus faecalis</i> Is Associated with Increased Resistance to Ceftriaxone and CarbapenemsKavindra V Singh, Barbara E Murray
Nature Reviews. Microbiology|March 17, 2012
The rise of the Enterococcus: beyond vancomycin resistanceCesar A Arias, Barbara E Murray
Pageof 20